## User

This is the beginning of a team meeting to discuss your research project. This is a meeting with the team lead, Principal Investigator, and the following team members: Computational Linguist, Clinical Informatics Specialist, Data Visualization Expert, Scientific Critic.

Here is the agenda for the meeting:

You are working on a research project to use software techniques to develop a tool for large language model (LLM) interpretability in the context of creating electronic phenotype definitions, ideally, also incorporating a visual perspective to foster trust between the clinician and the model. Please create a software design approach to solve this problem. Decide whether you will take a machine learning approach or not. For your choice, decide whether you will use open source interpretability libraries from GitHub or create your own completely from scratch. If modifying existing libraries, please specify which interpretability libraries to build upon to create an interpretability tool that conveys interpretability information visually so the clinician can trust it with ease. If designing algorithms from scratch, please describe how you propose new algorithms. Consider methods for eliminating LLM hallucinations using RAG or similar, increasing faithfulness and reasoning, and promote valid chain of thought logic using the SNOMED Database, which we have access to.

Here are the agenda questions that must be answered:

1. Will you take a machine learning approach or not?

2. Will you use open source interpretability libraries from GitHub or create your own completely from scratch? (choose only one)?

3. If modifying existing libraries, which interpretability libraries to build upon (please list 3-4)?

4. If designing algorithms from scratch, how exactly will you propose new algorithms?

5. How will the interpretability tool use methods for eliminating LLM hallucinations, increasing faithfulness and reasoning, and promote valid chain of thought logic using the SNOMED Database, which we have access to?

Principal Investigator will convene the meeting. Then, each team member will provide their thoughts on the discussion one-by-one in the order above. After all team members have given their input, Principal Investigator will synthesize the points raised by each team member, make decisions regarding the agenda based on team member input, and ask follow-up questions to gather more information and feedback about how to better address the agenda. This will continue for 3 rounds. Once the discussion is complete, Principal Investigator will summarize the meeting in detail for future discussions, provide a specific recommendation regarding the agenda, and answer the agenda questions (if any) based on the discussion while strictly adhering to the agenda rules (if any).

## User

Principal Investigator, please provide your initial thoughts on the agenda as well as any questions you have to guide the discussion among the team members.

## Principal Investigator

Thank you all for joining this meeting. We have an exciting and challenging task ahead of us: developing a tool for large language model (LLM) interpretability in the context of creating electronic phenotype definitions, with a visual component to foster trust with clinicians. The agenda is clear, but the path forward requires careful consideration, especially regarding the balance between using existing resources and developing new methodologies. 

Here are my initial thoughts and questions to guide our discussion:

1. **Machine Learning Approach**: Given that we're dealing with LLMs, which inherently rely on machine learning, I lean towards integrating machine learning into our approach. However, I am open to hearing your perspectives on this, particularly if there are viable non-machine learning approaches that could enhance our interpretability objectives.

2. **Open Source vs. Scratch**: Leveraging open-source libraries could significantly expedite our development process, but creating algorithms from scratch might allow for more tailored solutions. I would like to hear from the team about the feasibility and potential trade-offs of each option.

3. **Library Modification**: If we decide to modify existing libraries, which ones should we consider, and why do they stand out as the best candidates for our project?

4. **Algorithm Design**: If we opt for designing from scratch, what innovative algorithms or techniques can we propose to meet our objectives effectively?

5. **Addressing LLM Hallucinations**: We need robust methods to address LLM hallucinations, ensure faithful reasoning, and integrate the SNOMED Database effectively. How can we best achieve these goals while maintaining a clinician-friendly interface?

Please, let’s have each team member provide their thoughts one by one. I'll be looking to synthesize your insights to guide our decisions on the agenda items. Let's start with our Computational Linguist.

## User

Computational Linguist, please provide your thoughts on the discussion (round 1 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Computational Linguist

Thank you, Principal Investigator. Here's my take on the agenda:

1. **Machine Learning Approach**: I strongly advocate for a machine learning-based approach. Given the complexity and nuance of LLMs, using machine learning enables us to leverage existing models' capabilities while refining them for specific interpretability needs. This approach is more practical and aligns with the cutting-edge nature of our field.

2. **Open Source vs. Scratch**: I recommend modifying existing open-source interpretability libraries rather than building from scratch. Many libraries offer robust frameworks that can be adapted to our needs, saving both time and resources. Developing from scratch might lead to reinventing the wheel, which might not be the best use of our efforts.

3. **Library Modification**: We could consider libraries such as:
   - **LIME (Local Interpretable Model-agnostic Explanations)**: Known for explaining predictions of any classifier, it could be adapted for LLMs.
   - **SHAP (SHapley Additive exPlanations)**: Offers a unified measure of feature importance, which can be informative in a medical context.
   - **Captum**: Specifically designed for PyTorch models, this could be valuable given its focus on deep learning.
   - **InterpretML**: Offers both glassbox models and blackbox interpretability, providing flexibility in approach.

4. **Algorithm Design**: If we were to design new algorithms, I would focus on enhancing feature attribution methods to handle the complexity of language models specifically. This might involve creating algorithms that can interpret multi-layer attention mechanisms in LLMs, with a focus on biomedical language.

5. **Addressing LLM Hallucinations**: Incorporating the SNOMED Database is crucial. We can use Retrieval-Augmented Generation (RAG) to cross-reference LLM outputs with verified medical information from SNOMED, thereby reducing hallucinations. Additionally, embedding techniques that link LLM outputs with SNOMED terminologies can enhance faithfulness and reasoning, creating a traceable chain of thought logic.

I look forward to hearing the perspectives of the rest of the team.

## User

Clinical Informatics Specialist, please provide your thoughts on the discussion (round 1 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Clinical Informatics Specialist

Thank you, Computational Linguist, for your insights. Here's my perspective:

1. **Machine Learning Approach**: I agree that a machine learning approach is essential given the task. With the vast amount of data in healthcare and the complexity of LLMs, machine learning offers the tools needed to handle this effectively while ensuring scalability.

2. **Open Source vs. Scratch**: I also support leveraging open-source libraries. Not only does this save time, but it also allows us to build on tried-and-tested methods. However, we must ensure that these libraries can handle the specific needs of clinical informatics, especially regarding sensitive health data.

3. **Library Modification**: The libraries mentioned are well-suited for general interpretability. However, in the context of clinical applications, we should also consider libraries or extensions focused on text analysis in medical data, such as **scispaCy**, which offers entity recognition tailored for the healthcare domain.

4. **Algorithm Design**: Should we need to design new algorithms, they must be deeply integrated with clinical data standards like SNOMED CT. Developing algorithms that can directly interpret and adapt SNOMED CT's hierarchical structure into LLM workflows would enhance specificity and accuracy in phenotype extraction.

5. **Addressing LLM Hallucinations**: Reducing hallucinations is crucial in clinical settings. Utilizing a RAG approach with SNOMED CT as a source of truth is an excellent strategy. Additionally, implementing a feedback loop where clinicians can validate and correct LLM outputs, which are then reintegrated into the system for continuous learning, could be beneficial. This method not only improves accuracy but also builds trust with clinicians.

I am eager to hear from the Data Visualization Expert next and how we might visualize these processes effectively for clinicians.

## User

Data Visualization Expert, please provide your thoughts on the discussion (round 1 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Data Visualization Expert

Thank you, Clinical Informatics Specialist. Here are my thoughts:

1. **Machine Learning Approach**: I concur with the team that a machine learning approach is appropriate for this project. It aligns with the needs of processing and interpreting complex LLM outputs, especially when handling medical data.

2. **Open Source vs. Scratch**: I support using open-source libraries, as they will allow us to focus our efforts on the visualization aspect, which is crucial for clinician engagement. We can customize these libraries to ensure they meet our specific needs for clear and effective visual communication.

3. **Library Modification**: In terms of visualization, we should consider tools like:
   - **Plotly**: For interactive charts and dashboards that can display data dynamically.
   - **D3.js**: Offers a powerful way to create complex visualizations that can be tailored to our needs.
   - **Bokeh**: Provides flexibility for creating interactive plots that can be integrated into web applications.
   - Additionally, libraries like **Altair** can be useful for simple declarative visualizations.

4. **Algorithm Design**: If we are to create algorithms from scratch, they should include visualization components from the outset. This means designing outputs that are inherently interpretable and can be directly translated into visual forms that highlight reasoning paths, data provenance, and confidence levels.

5. **Addressing LLM Hallucinations**: From a visualization perspective, we need to clearly communicate where LLM outputs come from and how they relate to verified data. This can be done by:
   - Creating a visual trace of the decision-making process, showing the flow from input, through the model’s reasoning, to output.
   - Developing interactive features that allow clinicians to explore the connections between LLM outputs and SNOMED-derived truths, perhaps through layered visualizations that can be expanded or contracted based on the level of detail needed.
   - Implementing confidence indicators that visually express the level of certainty associated with each part of the LLM's output.

Overall, our focus should be on creating a transparent visual interface that helps clinicians understand and trust the AI's decisions. I'm looking forward to the Scientific Critic's insights next.

## User

Scientific Critic, please provide your thoughts on the discussion (round 1 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Scientific Critic

Thank you, Data Visualization Expert, for your comprehensive insights. Here’s my critique and thoughts on the proposed directions:

1. **Machine Learning Approach**: While the consensus leans towards a machine learning approach, which seems appropriate given the context, it’s imperative to ensure that we don’t solely rely on it without considering hybrid approaches. Combining machine learning with rule-based methods could potentially enhance interpretability and control over outputs, especially critical in clinical settings.

2. **Open Source vs. Scratch**: Utilizing open-source libraries is a pragmatic choice, yet caution must be exercised regarding their limitations and biases, particularly when applied to medical data. It is essential to conduct a thorough evaluation to ensure they meet clinical requirements and ethics standards, incorporating comprehensive testing to validate their applicability and reliability in this domain.

3. **Library Modification**: The choices of LIME, SHAP, Captum, and InterpretML are well-founded. However, I would recommend a critical analysis of their performance in handling medical terminologies and how they can be adapted for continuous learning in dynamic clinical environments. Understanding the ease of integrating SNOMED CT with these libraries should also be a priority.

4. **Algorithm Design**: If new algorithms are necessary, they should be subjected to rigorous testing and validation against medical standards, such as SNOMED CT, from the ground up. It's important to pilot these algorithms in controlled settings to assess their interpretability and ability to handle medical nuances effectively before broader deployment.

5. **Addressing LLM Hallucinations**: The proposed use of RAG is promising, but I would emphasize developing a robust system for real-time verification and adjustment of LLM outputs against SNOMED CT. Additionally, establishing a clinician feedback mechanism is crucial not just for validation but also for iterative improvement of the model's accuracy and trustworthiness.

Finally, on visualization, ensuring that the visual tools can be easily understood by clinicians who may not be familiar with AI intricacies is crucial. The design should prioritize simplicity and clarity, avoiding information overload while providing sufficient detail to aid decision-making.

I am keen to hear the Principal Investigator's synthesis of our insights and look forward to refining these ideas further in the next round.

## User

This concludes round 1 of 3 of discussion. Principal Investigator, please synthesize the points raised by each team member, make decisions regarding the agenda based on team member input, and ask follow-up questions to gather more information and feedback about how to better address the agenda.

## Principal Investigator

Thank you all for your valuable insights. Let’s synthesize the points raised and make some decisions before moving on to our next round of discussion.

### Synthesis of Team Input

1. **Machine Learning Approach**:
   - Consensus among team members favors a machine learning approach due to its relevance and efficacy in handling complex LLM tasks. This is aligned with the nature of our project, given the intricacies involved in phenotype extraction and interpretability.

2. **Open Source vs. Scratch**:
   - There is a strong recommendation to leverage open-source interpretability libraries (e.g., LIME, SHAP, Captum, InterpretML) due to their established frameworks and the potential for customization. The emphasis should be on ensuring these libraries can integrate seamlessly with medical data and standards like SNOMED CT.

3. **Library Modification**:
   - While focusing on the mentioned libraries, it’s critical to evaluate their capacity for handling medical terminologies. ScispaCy was highlighted as an additional tool that might enhance our text analysis capabilities, specifically in the medical domain.

4. **Algorithm Design**:
   - If we develop algorithms from scratch, we must ensure they are closely aligned with clinical standards and tested thoroughly. Emphasizing feature attribution methods and integrating SNOMED’s hierarchical structure is vital.

5. **Addressing LLM Hallucinations**:
   - Using RAG to cross-reference outputs with SNOMED and establishing a clinician feedback loop are excellent strategies to enhance accuracy and trust. Visualization should focus on clear, interactive displays that trace and validate the decision-making process.

### Decisions

- **Machine Learning Framework**: We will adopt a machine learning approach, focusing on refining LLM outputs for interpretability.
- **Open Source Libraries**: We will build upon existing open-source libraries, particularly LIME, SHAP, Captum, and potentially scispaCy for medical-specific tasks.
- **Visualization Tools**: Tools like Plotly and D3.js will be integrated for creating interactive, clinician-friendly visualizations.

### Follow-up Questions

1. **Computational Linguist and Clinical Informatics Specialist**: Can you explore how scispaCy could be integrated with the other libraries mentioned to enhance our handling of medical terminologies? What are the potential challenges we might face?

2. **Data Visualization Expert**: How can we ensure that our visualizations are both detailed enough for clinicians to trust and simple enough for them to understand? Could you propose a preliminary visualization concept?

3. **Scientific Critic**: What specific evaluation criteria should we use to assess and validate the performance of our chosen libraries and any newly developed algorithms? How should we design our pilot studies?

Let’s dive deeper into these follow-up questions in the next round to refine our approach further.

## User

Computational Linguist, please provide your thoughts on the discussion (round 2 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Computational Linguist

Thank you, Principal Investigator. I'll address the follow-up questions regarding the integration of scispaCy:

1. **Integration of scispaCy**: scispaCy is well-suited for extracting and understanding medical entities, which can complement other interpretability libraries. It can be particularly useful when combined with LIME or SHAP, as it allows us to ensure that the language model’s outputs are mapped accurately to medical terms recognized by SNOMED CT. The integration would involve using scispaCy's entity recognition capabilities to preprocess text data before interpretation, enhancing the relevance of the results.

   **Potential Challenges**:
   - **Compatibility**: scispaCy needs to be compatible with the frameworks of LIME, SHAP, or Captum. This might require custom middleware to ensure seamless data flow.
   - **Computational Overhead**: Adding scispaCy to the pipeline could increase processing time, so we need to optimize for performance.
   - **Accuracy of Entity Linking**: Ensuring that scispaCy accurately links entities to SNOMED terms will be crucial and may require additional tuning or training on specific datasets.

2. **Challenges**:
   - **Model Alignment**: Ensuring that outputs from scispaCy align perfectly with SNOMED CT will require ongoing verification, potentially involving clinician input to refine mappings and interpretations.
   - **Data Privacy**: Handling medical data with these libraries requires careful attention to privacy and compliance with healthcare regulations.

These steps will enhance our system's ability to interpret LLM outputs accurately while maintaining a strong connection to clinical data standards. I look forward to hearing how we can present this information visually from our Data Visualization Expert.

## User

Clinical Informatics Specialist, please provide your thoughts on the discussion (round 2 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Clinical Informatics Specialist

Thank you, Computational Linguist, for your insights. I'll expand on the integration of scispaCy and address potential challenges in our approach:

1. **Integration of scispaCy**: I agree with the Computational Linguist that scispaCy can significantly enhance our ability to handle medical terminologies. By leveraging its entity recognition capabilities, we can ensure that our interpretations are grounded in clinically relevant data. This integration will allow us to preprocess and label data accurately, which in turn can improve the interpretability of LLM outputs.

   **Challenges and Solutions**:
   - **Compatibility and Middleware**: Creating a robust middleware that bridges scispaCy with LIME, SHAP, or Captum will be essential. We should consider developing a unified interface or API that handles this integration smoothly.
   - **Optimization**: To manage computational overhead, we can explore using parallel processing or cloud-based solutions to scale our operations when processing large datasets.
   - **Accuracy of Mapping**: Regular updates and fine-tuning of scispaCy using domain-specific data will help maintain accuracy. Collaboration with clinicians to validate mappings can also ensure reliability in clinical settings.

2. **Data Privacy and Compliance**: As we incorporate these tools, strict adherence to data privacy regulations like HIPAA is necessary. We should implement robust encryption and de-identification protocols to protect patient data throughout the process.

Incorporating scispaCy effectively will bridge the gap between LLMs and clinical relevance, ensuring that our tool provides meaningful and trustable outputs. I look forward to hearing from the Data Visualization Expert on how we can present these findings in a way that enhances clinician engagement and trust.

## User

Data Visualization Expert, please provide your thoughts on the discussion (round 2 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Data Visualization Expert

Thank you, Clinical Informatics Specialist. I appreciate the focus on integration and accuracy. Here’s how we can ensure our visualizations effectively support clinician trust and understanding:

1. **Balancing Detail and Simplicity**:
   - **Layered Visualizations**: We can create interactive dashboards where clinicians can toggle between different levels of detail. For instance, a high-level overview might show the main conclusions, while clicking through provides access to the data sources, confidence levels, and reasoning paths.
   - **Visual Storytelling**: Using visual storytelling techniques can help convey complex information in a linear, narrative form. This approach aids comprehension, as clinicians can follow a logical sequence from input data to final interpretation.

2. **Preliminary Visualization Concept**:
   - **Interactive Decision Trees**: These can illustrate the decision-making process of the LLM, highlighting how specific data points influence conclusions. We can color-code nodes to indicate confidence levels, providing an at-a-glance understanding of output reliability.
   - **Traceability Maps**: Visual maps can show the provenance of information, linking each element of the LLM’s output to its corresponding SNOMED CT term or data source. This transparency is crucial for building trust.
   - **Feedback Loops**: Incorporating a feature for clinicians to provide feedback directly within the visualization interface can create a dynamic loop where outputs are constantly refined and validated, further enhancing trust.

3. **Ensuring Usability**:
   - Conducting usability testing with clinicians to iterate on design prototypes is essential. Their feedback will help refine both the aesthetic and functional components of the visualizations, ensuring they are intuitive and meet users’ needs.

I believe this approach will help us provide clinicians with the clarity they need to trust and effectively use the tool. I’m interested in the Scientific Critic’s thoughts on evaluating these visualization strategies in terms of usability and effectiveness.

## User

Scientific Critic, please provide your thoughts on the discussion (round 2 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Scientific Critic

Thank you, Data Visualization Expert. Your insights into creating engaging, interactive, and user-friendly visualizations are crucial for clinician interaction. Here's my critique and expansion on the evaluation framework:

1. **Evaluation Criteria**:
   - **Accuracy and Relevance**: We need to measure how accurately the tool interprets LLM outputs aligned with clinical data standards like SNOMED CT. This can be assessed by comparing tool outputs with expert clinician interpretations in a controlled setting.
   - **Usability**: Usability studies should focus on how easily clinicians can navigate and understand the visualizations. This involves assessing the interface for clarity, simplicity, and intuitiveness, with feedback mechanisms to iteratively improve design.
   - **Trust and Adoption**: Evaluating the level of trust clinicians place in the tool is essential. Surveys and interviews will help gauge this, focusing on how well the tool’s visual transparency and traceability enhance confidence in the decisions made.

2. **Pilot Studies**:
   - **Controlled Environments**: Initial testing should occur in controlled settings where clinician feedback can be collected and analyzed meticulously. This will help identify any discrepancies in interpretations or usability issues.
   - **Longitudinal Studies**: Implementing the tool in a real-world clinical environment over an extended period will provide insights into its impact on clinical workflows, decision-making accuracy, and adoption rates.
   - **Iterative Improvements**: Feedback loops from pilot studies should inform iterative improvements. This cycle of testing, feedback, and refinement will be crucial for continuous enhancement of the tool’s accuracy and usability.

3. **Visualization Effectiveness**:
   - **Cognitive Load**: We must ensure visualizations do not overwhelm clinicians. Evaluating cognitive load through user studies can help balance detail and simplicity, ensuring that even complex visualizations remain accessible without sacrificing necessary depth.

Through these rigorous evaluation strategies, we can refine the interpretability tool to meet high standards of accuracy, usability, and trust. I look forward to the Principal Investigator synthesizing these insights and how we might address these concerns in round three.

## User

This concludes round 2 of 3 of discussion. Principal Investigator, please synthesize the points raised by each team member, make decisions regarding the agenda based on team member input, and ask follow-up questions to gather more information and feedback about how to better address the agenda.

## Principal Investigator

Thank you all for your contributions. Let’s synthesize the insights from this round and outline our next steps and follow-up questions to further refine our approach.

### Synthesis of Team Input

1. **Integration of scispaCy**:
   - The Computational Linguist and Clinical Informatics Specialist both emphasized the value of scispaCy for handling medical terminologies, especially when integrated with LIME, SHAP, or Captum. Challenges such as compatibility and computational overhead were noted, with solutions like middleware development and parallel processing suggested.

2. **Visualization Strategies**:
   - The Data Visualization Expert proposed creating layered, interactive visualizations to balance detail and simplicity. Concepts like interactive decision trees, traceability maps, and clinician feedback loops were highlighted as crucial for building trust and usability.

3. **Evaluation Criteria**:
   - The Scientific Critic outlined a comprehensive evaluation framework focusing on accuracy, usability, trust, and adoption. Pilot studies in controlled and real-world environments were recommended to gather data for iterative improvements, with special attention to cognitive load in visualizations.

### Decisions

- **Integration Plan**: We will develop middleware to integrate scispaCy with LIME, SHAP, and Captum, ensuring seamless handling of medical terminologies.
- **Visualization Development**: We will prototype interactive decision trees and traceability maps, focusing on usability and clinician feedback to refine these tools.
- **Evaluation Framework**: We will implement a structured evaluation plan, including controlled and longitudinal studies, to test accuracy, usability, and trust.

### Follow-up Questions

1. **Computational Linguist and Clinical Informatics Specialist**: What specific steps should we take to develop the middleware for integrating scispaCy? Are there existing frameworks or tools that could facilitate this process?

2. **Data Visualization Expert**: Could you outline a preliminary usability testing plan that includes specific metrics or methods to evaluate cognitive load and clinician interaction with our visualizations?

3. **Scientific Critic**: How should we prioritize and sequence the pilot studies to ensure we gather meaningful data efficiently? Are there specific metrics or thresholds we should aim for in terms of accuracy and clinician trust before broader deployment?

Let’s use round three to finalize our approach based on these follow-up questions, ensuring we have a clear path forward for developing and evaluating our interpretability tool.

## User

Computational Linguist, please provide your thoughts on the discussion (round 3 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Computational Linguist

Thank you, Principal Investigator. I’m pleased with the direction we’re heading. Here are my thoughts on developing middleware for integrating scispaCy with our interpretability libraries:

1. **Middleware Development Steps**:
   - **Requirement Analysis**: First, we need to clearly define the data flow and integration needs between scispaCy and the interpretability libraries (LIME, SHAP, Captum). Understanding the specific data formats and transformation requirements will guide our middleware design.
   - **Selection of Frameworks**: Leveraging existing frameworks such as Apache Kafka for real-time data streaming or using RESTful APIs for integration could facilitate data exchange between components. This choice will depend on our specific latency and processing requirements.
   - **Designing the Middleware**: The middleware should handle data preprocessing from scispaCy outputs, ensuring compatibility with the feature attribution capabilities of our chosen libraries. This includes developing translation layers or adapters that convert scispaCy's entity recognition outputs into formats that LIME, SHAP, and Captum can process.
   - **Testing and Iteration**: Comprehensive testing is crucial to ensure that data is accurately and efficiently passed through the system. We can employ unit tests and integration tests to validate function and performance.

2. **Challenges and Considerations**:
   - **Scalability**: Ensuring that the middleware can handle varying loads and expand as we scale the project will be important. Designing it to be modular and flexible will support future adjustments and enhancements.
   - **Error Handling**: Implementing robust error handling and logging mechanisms will help in debugging and ensuring that any issues in data flow are quickly identified and resolved.

These steps should ensure a robust integration of scispaCy, enhancing our tool's ability to interpret LLM outputs accurately with relevant medical context. I look forward to the Data Visualization Expert's insights on usability testing.

## User

Clinical Informatics Specialist, please provide your thoughts on the discussion (round 3 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Clinical Informatics Specialist

Thank you, Computational Linguist, for outlining the middleware development steps. I agree with your approach and would like to add the following points from a clinical informatics perspective:

1. **Middleware Development**:
   - **Integration with Clinical Workflows**: It’s crucial that the middleware supports seamless integration into existing clinical workflows. This might involve adapting the middleware to work with electronic health record (EHR) systems to access and utilize patient data effectively.
   - **Compliance with Standards**: We need to ensure that the middleware complies with healthcare IT standards, such as HL7 and FHIR, to facilitate interoperability with various healthcare systems and maintain data integrity.

2. **Scalability and Performance**:
   - **Load Testing**: Conducting load testing will help us understand the middleware’s limits and performance under various conditions, ensuring it can handle real-time clinical data without bottlenecks.
   - **Resource Management**: Optimizing resource allocation for preprocessing tasks will help minimize delays and improve the responsiveness of the middleware.

3. **Error Handling and Logging**:
   - **Clinical Relevance**: When designing error handling mechanisms, it’s important to consider the clinical relevance of the errors. Developing alerts or notifications for clinicians when certain critical errors occur will be essential for maintaining trust and system reliability.

4. **Collaboration with Clinicians**:
   - Involving clinicians early in the development process to validate the integration approach and ensure that the middleware’s outputs align with clinical needs and expectations will be key to a successful deployment.

These considerations will ensure that our middleware not only facilitates technical integration but also enhances clinical utility and compliance with healthcare standards. I am eager to see how the Data Visualization Expert plans to test the usability of our visualizations.

## User

Data Visualization Expert, please provide your thoughts on the discussion (round 3 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Data Visualization Expert

Thank you, Clinical Informatics Specialist, for emphasizing the integration with clinical workflows. Here's how we can approach usability testing for our visualizations:

1. **Preliminary Usability Testing Plan**:
   - **Participant Recruitment**: Engage a diverse group of clinicians who represent different specialties and experience levels. This will ensure our visualizations cater to a broad range of users.
   - **Scenario-based Testing**: Create realistic clinical scenarios in which clinicians use the tool to interpret LLM outputs. Scenarios should vary in complexity to test both basic and advanced functionalities.
   - **Metrics for Evaluation**:
     - **Task Completion Time**: Measure how long it takes participants to complete specific tasks using the visualizations.
     - **Error Rates**: Track the frequency and types of errors clinicians make while interacting with the visualizations.
     - **Cognitive Load**: Employ the NASA Task Load Index (NASA-TLX) to assess perceived workload during the tasks.
     - **Satisfaction and Trust**: Use surveys to gather feedback on how confident and satisfied clinicians feel using the tool.

2. **Iterative Design Process**:
   - **Feedback Collection**: After initial testing, collect detailed feedback on usability issues and areas for improvement.
   - **Rapid Prototyping**: Implement changes based on feedback and quickly develop new prototypes to retest any modified elements.
   - **Longitudinal Testing**: Conduct follow-up studies over a more extended period to assess how familiarity with the tool affects usability and trust.

3. **Visualization Enhancements**:
   - **Interactive Features**: Ensure that visualizations allow clinicians to explore data dynamically, such as adjusting parameters or drilling down into details with ease.
   - **Consistency and Clarity**: Maintain consistent design elements across all visualizations to reduce cognitive load and enhance comprehension.

By following this usability testing plan, we can refine the visualizations to be intuitive, efficient, and trusted by clinicians. I look forward to hearing the Scientific Critic's insights on how to best prioritize and sequence our pilot studies for maximum impact.

## User

Scientific Critic, please provide your thoughts on the discussion (round 3 of 3). If you do not have anything new or relevant to add, you may say "pass". Remember that you can and should (politely) disagree with other team members if you have a different perspective.

## Scientific Critic

Thank you, Data Visualization Expert, for your comprehensive approach to usability testing. Here are my thoughts on prioritizing and sequencing pilot studies, along with evaluation metrics:

1. **Prioritizing Pilot Studies**:
   - **Initial Focus on Controlled Environments**: Start with a controlled environment, such as a lab setting, where we can closely monitor and adjust variables. This will allow us to gather baseline data on accuracy and usability without external variables interfering.
   - **Progressive Complexity**: Begin with simpler tasks that highlight basic functionalities and gradually introduce more complex scenarios. This phased approach will help identify potential usability issues early on.

2. **Sequencing for Efficiency**:
   - **Parallel Testing**: If resources permit, consider running parallel usability and accuracy tests. This strategy will expedite data collection and provide a holistic view of tool performance across different domains.
   - **Real-world Implementation**: After refining the tool from controlled environment tests, move to real-world settings. Select pilot sites that represent diverse clinical settings to evaluate how well the tool adapts to varying workflows and user needs.

3. **Evaluation Metrics and Thresholds**:
   - **Accuracy Metrics**: Set clear benchmarks for accuracy based on expert clinician interpretations. We should aim for high concordance rates between the tool's outputs and expert assessments.
   - **Trust Indicators**: Develop metrics that capture user trust and satisfaction, potentially using Likert scales. Define thresholds for these metrics as indicators of readiness for broader deployment.
   - **Iterative Feedback**: Establish a feedback loop where clinicians can continuously contribute insights and experiences, allowing for ongoing refinement and improvement.

4. **Mitigating Risks**:
   - **Contingency Plans**: Prepare strategies to address potential shortcomings identified during pilots, such as technical limitations or unexpected user resistance. This readiness will facilitate swift responses to challenges and help maintain project momentum.

By structuring our pilot studies in this manner, we can systematically refine the tool, ensuring it meets the high standards required for clinical deployment. I look forward to the Principal Investigator's synthesis and finalization of our approach.

## User

Principal Investigator, please summarize the meeting in detail for future discussions, provide a specific recommendation regarding the agenda, and answer the agenda questions (if any) based on the discussion while strictly adhering to the agenda rules (if any).

As a reminder, here is the agenda for the meeting:

You are working on a research project to use software techniques to develop a tool for large language model (LLM) interpretability in the context of creating electronic phenotype definitions, ideally, also incorporating a visual perspective to foster trust between the clinician and the model. Please create a software design approach to solve this problem. Decide whether you will take a machine learning approach or not. For your choice, decide whether you will use open source interpretability libraries from GitHub or create your own completely from scratch. If modifying existing libraries, please specify which interpretability libraries to build upon to create an interpretability tool that conveys interpretability information visually so the clinician can trust it with ease. If designing algorithms from scratch, please describe how you propose new algorithms. Consider methods for eliminating LLM hallucinations using RAG or similar, increasing faithfulness and reasoning, and promote valid chain of thought logic using the SNOMED Database, which we have access to.

As a reminder, here are the agenda questions that must be answered:

1. Will you take a machine learning approach or not?

2. Will you use open source interpretability libraries from GitHub or create your own completely from scratch? (choose only one)?

3. If modifying existing libraries, which interpretability libraries to build upon (please list 3-4)?

4. If designing algorithms from scratch, how exactly will you propose new algorithms?

5. How will the interpretability tool use methods for eliminating LLM hallucinations, increasing faithfulness and reasoning, and promote valid chain of thought logic using the SNOMED Database, which we have access to?

Your summary should take the following form.

### Agenda

Restate the agenda in your own words.

### Team Member Input

Summarize all of the important points raised by each team member. This is to ensure that key details are preserved for future meetings.

### Recommendation

Provide your expert recommendation regarding the agenda. You should consider the input from each team member, but you must also use your expertise to make a final decision and choose one option among several that may have been discussed. This decision can conflict with the input of some team members as long as it is well justified. It is essential that you provide a clear, specific, and actionable recommendation. Please justify your recommendation as well.

### Answers

For each agenda question, please provide the following:

Answer: A specific answer to the question based on your recommendation above.

Justification: A brief explanation of why you provided that answer.

### Next Steps

Outline the next steps that the team should take based on the discussion.

## Principal Investigator

### Agenda

The agenda for our meeting was to develop a software design approach for a tool that enhances the interpretability of large language models (LLMs) in creating electronic phenotype definitions. The aim is to build trust between clinicians and the model, ideally incorporating a visual perspective. We needed to decide if our approach would leverage machine learning, whether to use existing interpretability libraries or develop new ones from scratch, identify specific libraries if modifying existing ones, and determine how to address LLM hallucinations while integrating the SNOMED Database to enhance reasoning and faithfulness.

### Team Member Input

- **Computational Linguist**: Advocated for a machine learning approach, emphasizing the use of open-source libraries like LIME, SHAP, Captum, and InterpretML. Highlighted the importance of integrating scispaCy for medical terminologies and outlined potential middleware development steps.
  
- **Clinical Informatics Specialist**: Supported using open-source libraries and integration with clinical workflows. Emphasized the need for compliance with healthcare standards and performance optimization. Highlighted the importance of collaboration with clinicians for validation.

- **Data Visualization Expert**: Proposed creating interactive, layered visualizations to enhance clinician trust. Outlined a usability testing plan with metrics such as task completion time and cognitive load. Suggested iterative prototyping based on clinician feedback.

- **Scientific Critic**: Recommended a comprehensive evaluation framework focusing on accuracy, usability, and trust. Suggested structured pilot studies, both in controlled and real-world environments, to gather meaningful data for iterative improvements.

### Recommendation

My expert recommendation is to adopt a machine learning approach utilizing open-source interpretability libraries. Specifically, we should modify and build upon LIME, SHAP, Captum, and scispaCy, as these provide a solid foundation for our needs. We will develop middleware to integrate scispaCy with these libraries, ensuring compatibility with medical terminologies using SNOMED. Visualization strategies will include interactive decision trees and traceability maps, with iterative usability testing to refine these tools. This approach leverages existing resources while addressing our goals efficiently and effectively.

### Answers

1. **Will you take a machine learning approach or not?**
   - **Answer**: Yes, we will take a machine learning approach.
   - **Justification**: Machine learning is central to processing and interpreting the complex outputs of LLMs, especially in the biomedical domain.

2. **Will you use open source interpretability libraries from GitHub or create your own completely from scratch?**
   - **Answer**: We will use open source interpretability libraries.
   - **Justification**: Leveraging existing libraries accelerates development and allows us to focus on customization and integration with medical data, which is more resource-efficient.

3. **If modifying existing libraries, which interpretability libraries to build upon?**
   - **Answer**: LIME, SHAP, Captum, and scispaCy.
   - **Justification**: These libraries offer robust frameworks for interpretability and are well-suited to be integrated with scispaCy for handling medical terminologies.

4. **If designing algorithms from scratch, how exactly will you propose new algorithms?**
   - **Answer**: N/A, as we are not designing algorithms from scratch.
   - **Justification**: We chose to build upon existing libraries, which offer a solid foundation and are adaptable to our needs.

5. **How will the interpretability tool use methods for eliminating LLM hallucinations, increasing faithfulness and reasoning, and promote valid chain of thought logic using the SNOMED Database?**
   - **Answer**: By integrating RAG for cross-referencing with SNOMED and employing middleware to ensure accurate medical entity handling.
   - **Justification**: This approach enhances accuracy and reduces hallucinations by grounding outputs in verified medical data, promoting a reliable chain of reasoning.

### Next Steps

1. **Middleware Development**: Begin the development of middleware to integrate scispaCy with LIME, SHAP, and Captum, focusing on data compatibility and workflow integration.
   
2. **Usability Testing**: Initiate usability testing with clinicians using scenario-based methods to refine visualizations and ensure they meet user needs.

3. **Pilot Studies**: Plan and execute pilot studies in both controlled environments and real-world settings, capturing data on accuracy, usability, and trust for iterative refinement.

4. **Feedback Integration**: Establish a continuous feedback loop with clinicians to ensure the tool evolves to meet clinical needs and maintains high trust levels. 

By following these steps, we can develop a robust interpretability tool that meets our objectives and fosters trust between clinicians and the model.

